CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-04 | Chuang Emil Director | Grant or award · Phantom Units | +18,800 | 18,800 | ||
| 2025-07-18 | Chuang Emil Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2025-02-11 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +29,000 | 29,000 | ||
| 2025-02-11 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2025-02-11 | Finley John David CEO, CFO | Grant or award · Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2025-02-11 | Finley John David CEO, CFO | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2024-11-21 | Wei Binxian Director | Option exercise | +388 | 855 | ||
| 2024-11-21 | Williams Donald Allen Director | Option exercise | +388 | 728 | ||
| 2024-07-11 | Wei Binxian Director | Grant or award · Common Stock Options | +2,100 | 2,100 | ||
| 2024-07-11 | Fischbein Margery B. Director | Grant or award · Common Stock Options | +2,100 | 2,100 | ||
| 2024-07-11 | Williams Donald Allen Director | Grant or award · Common Stock Options | +2,100 | 2,100 | ||
| 2024-06-11 | Wei Binxian Director | Option exercise | +465 | 467 | ||
| 2024-06-11 | Williams Donald Allen Director | Option exercise | +340 | 340 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +2,735 | 3,568 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Shares withheld for taxes | −810 | $4.76 | $4K | 2,758 |
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +1,555 | 4,313 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Shares withheld for taxes | −461 | $4.76 | $2K | 3,852 |
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −2,735 | 0 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −1,555 | 0 | ||
| 2024-05-28 | Finley John David CEO, CFO, Director | Option exercise | +1,622 | 10,059 |
Page 4 of 12 · 233 trades